Mary Fenton

Mary Fenton

Director of Finance/CFO at CULLINAN THERAPEUTICS, INC.

Net worth: 108 880 $ as of 29/04/2024

60 year
Health Technology
Consumer Services
Commercial Services

Mary Fenton active positions

CompaniesPositionStartEnd
CULLINAN THERAPEUTICS, INC. Comptroller/Controller/Auditor 28/04/2024 -
Director of Finance/CFO 28/04/2024 -
Director/Board Member 05/12/2018 -
Chairman - 05/12/2018

Career history of Mary Fenton

Former positions of Mary Fenton

CompaniesPositionStartEnd
ONCORUS, INC. Director/Board Member 19/12/2019 26/07/2023
Independent Dir/Board Member 19/12/2019 26/07/2023
VERTEX PHARMACEUTICALS INCORPORATED Corporate Officer/Principal 30/09/2019 31/01/2021
Chief Operating Officer 30/04/2019 30/09/2019
Director of Finance/CFO 30/04/2019 30/09/2019
ACHILLION PHARMACEUTICALS, INC. Comptroller/Controller/Auditor 31/12/2005 27/12/2018
Director of Finance/CFO 31/12/2005 27/12/2018
Investor Relations Contact 30/09/2000 14/08/2018
Corporate Secretary 30/09/2000 31/01/2016
Corporate Officer/Principal 31/07/1991 30/09/2000
TOURMALINE BIO, INC. Chief Executive Officer 25/05/2023 -
Director of Finance/CFO 28/02/2021 -
President 25/05/2023 -

Training of Mary Fenton

College of the Holy Cross (Massachusetts) Undergraduate Degree
University of Connecticut School of Business Masters Business Admin

Statistics

International

United States 10
Belgium 2

Operational

Director of Finance/CFO 4
Comptroller/Controller/Auditor 2
Corporate Officer/Principal 2

Sectoral

Health Technology 7
Consumer Services 3
Commercial Services 3

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies3
ONCORUS, INC.

Health Technology

VERTEX PHARMACEUTICALS INCORPORATED

Health Technology

CULLINAN THERAPEUTICS, INC.

Health Technology

Private companies5

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

See company connections